
    
      3 formulations of GSK's MenACWY conjugate vaccine will be administered in a double-blind
      manner, while the 4th one will be single-blinded. Administration of the candidate vaccine or
      of the active control (Mencevax™ ACWY) will be done in an open manner. Subjects will receive
      one vaccine dose (GSK's MenACWY conjugate vaccine or Mencevax™ ACWY vaccine), and will have 2
      blood samples taken, before and one month after vaccination.
    
  